lansoprazole has been researched along with Aspergillosis in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Aspergillosis: Infections with fungi of the genus ASPERGILLUS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tsubokura, M | 1 |
Miura, Y | 1 |
Itokawa, T | 1 |
Murata, K | 1 |
Takei, N | 1 |
Higaki, T | 1 |
Murashige, N | 1 |
Kami, M | 1 |
Komatsu, T | 1 |
1 other study available for lansoprazole and Aspergillosis
Article | Year |
---|---|
Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antifungal Agents; Aspergillosis; | 2011 |